Tweets
When will this madness stop!? TNFi to treat OA (yet again). Adalimumab for "inflammatory" knee OA. And again it doesn't work. @RheumNow #EULAR2022 OP0229 https://t.co/htwyLTYwG4
Links:
Richard Conway @RichardPAConway ( View Tweet )
4 years 1 month ago
#POS0787 #EULAR2022 More data to support the association of Anti-Ribosomal P ab with Depression + Cognitive Dysfunction using functional MRI in #lupus. To screen for neuropsychiatric in ab+ patients @RheumNow https://t.co/9JQDImrHAt
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
4 years 1 month ago
✅ #EULAR2022 positive Phase 2 results for #deucravacitinib (TYK2 inhibitor) in systemic #Lupus with SRI(4) at 32W:
- DEU 3mg BID: 58.2% (p=0.0006)
- DEU 6mg BID: 49.5% (p=0.021)
- DEU 12mg QD: higher (but NS)
vs Placebo 34.4%
+ secondary endpoints.
https://t.co/QCWqW97tre
Laurent ARNAUD @Lupusreference ( View Tweet )
4 years 1 month ago
#Cytokine #StormHour 🌀🌪️
#EULAR2022
#Great session by Dr.Peter Nigrovic🔥
❓Why sJIA/AOSD often accompanied by MAS❓⚡️
#Always wondered about this!🤔
✅Multiple mechanisms at play
✅Whats New➡️IFN gamma switch
✅mTORC1 is the NEW PIECE in the puzzle of sJIA/AOSD/MAS!🧩🧩 https://t.co/xLzCABunMb
debaditya_roy @debaditya_roy ( View Tweet )
4 years 1 month ago
#EULAR2022 quote of the day. I was going to go to the fatigue session @eular_org but I was too tired and burnt out! @RheumNow
Janet Pope @Janetbirdope ( View Tweet )
4 years 1 month ago
Subcutaneous #methotrexate in #rheumatoidarthritis is safer and better tolerated with better continuation rates than oral #MTX
#eular2022 https://t.co/cjmKntsEMe
Volker Bahr @VolkerBahr ( View Tweet )
4 years 1 month ago
#Lovely slide when deep into the maze of AOSD!🌎🔍❓
#EULAR2022
⚡️Identify level of disease activity
⚡️Systemic/Articular?
⚡️Close monitoring
⚡️Identify non-responders early!
⏲️"DAVID" Project ongoing- validation of EULAR Disease Activity Score in AOSD!
Exciting times ahead!🔥 https://t.co/fuPPj4lEhs
debaditya_roy @debaditya_roy ( View Tweet )
4 years 1 month ago
I also wonder about the significance of Ro52. Some of the commonly observed features like gastrointestinal dysmotility are not captured. https://t.co/UPljYf65vH
Alberta Hoi @alberta_hoi ( View Tweet )
4 years 1 month ago
#EULAR2022
How to Manage (HOT): Lupus Nephritis
Voclosporin is the new CNI
long term reno-ischemic effects need to be looked at https://t.co/8RqayemaRu
EnvisionRheumat @ERheumat ( View Tweet )
4 years 1 month ago
#EULAR2022
WIN session
Sarcoidosis – an update for rheumatologists
Clinical Approach https://t.co/AYOEDsnDZ6
EnvisionRheumat @ERheumat ( View Tweet )
4 years 1 month ago
#EULAR2022 COVID orals
OP0172
Swedish COVID19-Reuma registry with n=414 ARD + 61 controls
RTX n=145, ABA n=21
In MVA, use of RTX, ABA were a/w lower Ab response. We've known this about RTX; growing data for ABA as well? https://t.co/Es9bA54m8E
Rheum Cat @rheum_cat ( View Tweet )
4 years 1 month ago
Excited to share our recent work "IPAF: What the Rheumatologist Needs to Know."
@jeffsparks @UnaMakris @DrDavidKarp @UTSW_LungLadies @UTSWRheum https://t.co/O0BsrRyHx8 https://t.co/R3lQMGFgUb
Elena Joerns @EJoerns ( View Tweet )
4 years 1 month ago
